➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
McKinsey
McKesson
Boehringer Ingelheim
Moodys

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

CONDYLOX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Condylox, and when can generic versions of Condylox launch?

Condylox is a drug marketed by Allergan and Teva Branded Pharm and is included in two NDAs.

The generic ingredient in CONDYLOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.

US ANDA Litigation and Generic Entry Outlook for Condylox

A generic version of CONDYLOX was approved as podofilox by PADDOCK LLC on January 29th, 2002.

  Start Trial

Drug patent expirations by year for CONDYLOX
Drug Prices for CONDYLOX

See drug prices for CONDYLOX

Recent Clinical Trials for CONDYLOX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
bioRASI, LLCPhase 3
Hyloris Developments SAPhase 3

See all CONDYLOX clinical trials

Pharmacology for CONDYLOX
Physiological EffectDecreased Mitosis

US Patents and Regulatory Information for CONDYLOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan CONDYLOX podofilox GEL;TOPICAL 020529-001 Mar 13, 1997 RX Yes Yes   Start Trial   Start Trial   Start Trial
Teva Branded Pharm CONDYLOX podofilox SOLUTION;TOPICAL 019795-001 Dec 13, 1990 AT RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Dow
Express Scripts
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.